The primary objectives of the NEDA study are to accurately identify the risks of pulmonary hypertension and its various causes, including the impact of age, region and other factors.

​

Examination of individual echo markers for abnormalities and the associated risk of death will help researchers identify specific risks in pulmonary hypertension. The NEDA database will allow researchers to answer a broad range of other questions about cardiac disease, such as reference ranges for each echo measurement performed, associations between variables in cardiac diseases and other diseases.

​

NEDA will support the study of the complex interaction between alterations of variables and specific cardiovascular diseases. From this understanding, experts plan to generate automated reporting systems, capable of accurately generating reports of echo examinations automatically. Strides in efficiency, accuracy and standardisation of reporting should be achievable outcomes, among others.